Clik here to view.
レビタスバイオがLeviSelect細胞除去・濃縮キット一式を発売
米カリフォルニア州メンロパーク （ビジネスワイヤ） — ライフサイエンス市場にエンドツーエンドの試料処理・細胞分析サービスを提供する一流企業のレビタスバイオ（www.levitasbio.com）は、免疫研究用のLeviSelect™細胞除去・濃縮キット一式を発表します。...
View ArticleClik here to view.
PHC Corporation of North America Launches PHCbi Brand VIP ECO® SMART...
WOOD DALE, Ill. PHC Corporation of North America, supplier of the PHCbi brand of cell preservation and growth products in North American and Latin American markets, announces the launch of the PHCbi...
View ArticleClik here to view.
Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility...
REHOVOT, Israel Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it has acquired a manufacturing facility in Modi’in, Israel, and...
View ArticleClik here to view.
Aleph Farms通过收购VBL Therapeutics设施和与ESCO Aster合作来提高产能
以色列雷霍沃特 (美国商业资讯)–首家直接通过非改良牛细胞生产人造牛排的公司Aleph Farms今天宣布，公司已经从生物技术公司VBL Therapeutics (Nasdaq: VBLT)收购了位于以色列莫迪因的一家生产设施和某些相关资产。此外，Aleph Farms已经与垂直整合的合同制造组织ESCO...
View ArticleClik here to view.
アレフ・ファームズがVBLセラピューティクスの施設買収とエスコ・アスターとの提携により生産能力を増強
イスラエル・レホボト （ビジネスワイヤ） — 非遺伝子組み換えウシ細胞から直接的に培養ステーキ肉を育てる初の企業であるアレフ・ファームズは本日、バイオテクノロジー企業のVBLセラピューティクス（Nasdaq:...
View ArticleClik here to view.
Cellusion Announces First Patient Transplanted iPSC-Derived Corneal...
TOKYO Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”) announced that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio University presented at...
View ArticleClik here to view.
Thermo Fisher Scientific与Arsenal Biosciences合作，支持自体T细胞疗法的临床制造
加州卡尔斯班 (美国商业资讯)–服务科学领域的全球领先公司Thermo Fisher Scientific与面向实体瘤设计先进嵌合抗原受体(CAR)-T细胞疗法的临床阶段细胞治疗公司Arsenal Biosciences, Inc....
View ArticleClik here to view.
Clik here to view.
OrganaBio Delivers RUO ＆ GMP LeukoPAC™ Collections to Singapore
MIAMI The monoclonal antibodies (mAbs) daratumumab, and elotuzumab have been approved by the U.S. Food and Drug Administration for treating multiple myeloma (MM) in 2015. Although clinical responses...
View ArticleClik here to view.
Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented...
FORT LEE, N.J. Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI), Rensselaer, New York, today announced the...
View ArticleClik here to view.
Next＆Bio and CSI Singapore Sign MOU for Organoid Collaboration
SEOUL, South Korea & SINGAPORE Next&Bio Inc. (Co-CEO: HyunSook Lee, Ji-Hun Yang), a company that has developed an organoid-based precision medicine drug discovery and development platform,...
View ArticleClik here to view.
AGCバイオロジクス、BravoAAV™・ProntoLVV™プラットフォームを立ち上げ、細胞および遺伝子療法プログラムのための柔軟で迅速なベクター開発と...
シアトル （ビジネスワイヤ） — AGCバイオロジクスは、世界的なバイオ医薬品受託開発・製造機構（CDMO: Biopharmaceutical Contract Development and Manufacturing...
View ArticleClik here to view.
Heartseed raises 2 billion JPY in series D funding to accelerate development...
TOKYO Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it has raised 2 billion JPY at Series D round,...
View ArticleClik here to view.
MEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on...
MOUNTAIN VIEW, Calif. MEDiC Life Sciences (“MEDiC”), a Silicon Valley biotech startup, today announced that it entered into a research collaboration with Bristol Myers Squibb (NYSE:BMY). In the...
View ArticleClik here to view.
Cellusion raises 2.83 Billion Yen (21 Million USD) in Series C Round
TOKYO Cellusion Inc. (Head Office: Tokyo; CEO: Shin Hatou; hereinafter referred to as “Cellusion”) announced that it has raised 2.83 billion yen (21 million USD) in Series C Round financing. New...
View ArticleClik here to view.
CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma Multiforme (GBM)...
BEIJING & BURLINGTON, Mass. CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and...
View ArticleClik here to view.
Desktop Health™ Introduces the PrintRoll™ Rotating Build Platform for the...
BOSTON Desktop Health — the trusted production-grade medical 3D printing brand of Desktop Metal, Inc. (NYSE: DM) — today announced a breakthrough in bioprinting with the launch of PrintRoll™, an...
View ArticleClik here to view.
Qihan Biotech Appoints Naxin Yao to its Board of Directors
HANGZHOU, China Hangzhou Qihan Biotech Co., Ltd. (“Qihan” or “Qihan Biotech” or “the Company”), an industry leader in applying multiplexable genome editing technology to cell therapies and organ...
View ArticleClik here to view.
HebeCell and Logomix Announce Collaboration for the Development of Next Gen...
BOSTON & TOKYO HebeCell Corp (HebeCell), a biotechnology company developing ProtoNK™ cell therapeutics based on its proprietary 3D PSC-NK manufacture platform, and Logomix Inc (Logomix), a...
View ArticleClik here to view.
Simple Planet, Korea’s Leading Cultivated Meat Company, Takes a Closer Step...
SEOUL, South Korea Simple Planet is a biotech food company that develops functional future food ingredients with a cell culture platform and cell organization technology. With a cell line...
View Article